| 11498923 |
Substituted imidazo[1,2-c]quinazolines as A2A antagonists |
Yeon-Hee Lim, Gioconda V. Gallo-Etienne, Joseph M. Kelly, Pauline C. Ting, Hongwu Wang |
2022-11-15 |
$883,400,000 |
| 10688082 |
Aminopyrazine compounds with A2A antagonist properties |
Junying Zheng, Walter Won, Pauline C. Ting, Guoqing Li, Dong Xiao +2 more |
2020-06-23 |
$115,870,000 |
| 10472347 |
Aminopyrazine compounds with A2A antagonist properties |
Rongze Kuang, Pauline C. Ting, Amjad Ali, Heping Wu, Andrew Stamford +6 more |
2019-11-12 |
$187,990,000 |
| 10138212 |
Aminoquinazoline compounds as A2A antagonist |
Amjad Ali, Rongze Kuang, Yeon-Hee Lim, Michael Man-Chu Lo, Pauline C. Ting +21 more |
2018-11-27 |
$94,550,000 |
| 9676780 |
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties |
Amjad Ali, Michael Man-Chu Lo, Yeon-Hee Lim, Andrew Stamford, Rongze Kuang +19 more |
2017-06-13 |
$92,938,000 |
| 8569312 |
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators |
Kevin D. McCormick, Li Dong, Christopher W. Boyce, Manuel de Lera Ruiz, Salem Fevrier +12 more |
2013-10-29 |
$46,137,000 |
| 8524697 |
C20-C21 substituted glucocorticoid receptor agonists |
John C. Anthes, Kevin D. McCormick, John Hey, Robert G. Aslanian, Purakkattle Biju +5 more |
2013-09-03 |
$73,082,000 |
| 8501747 |
Functionally selective alpha2C adrenoreceptor agonists |
Manuel de Lera Ruiz, Kevin D. McCormick, Christopher W. Boyce, Robert G. Aslanian, Younong Yu +5 more |
2013-08-06 |
$72,172,000 |
| 8476274 |
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators |
Kevin D. McCormick, Li Dong, Christopher W. Boyce, Manuel de Lera Ruiz, Salem Fevrier +12 more |
2013-07-02 |
$146,162,000 |
| 8324213 |
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators |
Kevin D. McCormick, Li Dong, Christopher W. Boyce, Manuel de Lera Ruiz, Salem Fevrier +12 more |
2012-12-04 |
$94,767,000 |
| 7879880 |
Substituted aniline derivatives useful as histamine H3 antagonists |
Daniel M. Solomon, Robert G. Aslanian, Manuel de Lera Ruiz, Kevin D. McCormick, Mwangi W. Mutahi +1 more |
2011-02-01 |
|
| 7846946 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
Robert G. Aslanian, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz, Pietro Mangiaracina +9 more |
2010-12-07 |
|
| 7638531 |
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists |
Mwangi W. Mutahi, Robert G. Aslanian, Christopher W. Boyce, Manuel de Lera Ruiz, Kevin D. McCormick +7 more |
2009-12-29 |
|
| 7635705 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
Robert G. Aslanian, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz, Pietro Mangiaracina +9 more |
2009-12-22 |
|
| 7531660 |
1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereof |
Manuel de Lera Ruiz, Robert G. Aslanian, Kevin D. McCormick, Chander Shekher Celly |
2009-05-12 |
$208,740,000 |
| 7408066 |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
Robert G. Aslanian, Ying Huang, Kevin D. McCormick, Mwangi W. Mutahi, Neng-Yang Shih +3 more |
2008-08-05 |
$376,228,000 |
| 7332604 |
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine |
Manuel de Lera Ruiz, Robert G. Aslanian, Kevin D. McCormick |
2008-02-19 |
$85,332,000 |
| 7300941 |
Non-imidazole compounds |
Robert G. Aslanian, Neng-Yang Shih, Pauline C. Ting, Stuart B. Rosenblum, Kevin D. McCormick +5 more |
2007-11-27 |
$287,299,000 |
| 7220735 |
Benzimidazolone histamine H3 antagonists |
Pauline C. Ting, Robert G. Aslanian, Christopher W. Boyce, Jianhua Cao, Pietro Mangiaracina +7 more |
2007-05-22 |
$108,242,000 |
| 7105505 |
Benzimidazole derivatives useful as histamine H3 antagonists |
Qingbei Zeng, Robert G. Aslanian, Christopher W. Boyce, Jianhua Cao, Joseph A. Kozlowski +7 more |
2006-09-12 |
$71,279,000 |
| 6951871 |
Indole derivatives useful as histamine H3 antagonists |
Robert G. Aslanian, Pietro Mangiaracina, Kevin D. McCormick, Mwangi W. Mutahi, Stuart B. Rosenblum |
2005-10-04 |
$159,976,000 |
| 6720328 |
Non-imidazole compounds |
Robert G. Aslanian, Neng-Yang Shih, Pauline C. Ting, Stuart B. Rosenblum, Kevin D. McCormick +5 more |
2004-04-13 |
$84,372,000 |
